Rodrigues Nádia Cristina Pinheiro, Andrade Mônica Kramer de Noronha
Departamento de Epidemiologia e Métodos Quantitativos em Saúde/Escola Nacional de Saúde Pública Sérgio Arouca/Fundação Oswaldo Cruz, Rio de Janeiro/Brasil and Departamento de Epidemiologia/Instituto de Medicina Social Hesio Cordeiro/Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil.
Programa Academico de Tuberculose/Faculdade de Medicina/Instituto de Doenças do Torax/Hospital Universitário Clementino Fraga Filho/ Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Front Med (Lausanne). 2024 Dec 18;11:1495428. doi: 10.3389/fmed.2024.1495428. eCollection 2024.
There are few studies in the literature evaluating post-COVID mortality in Brazil, along medium and long term, especially in those who presented severe clinical disease.
This study aims to investigate the factors associated with post-COVID mortality of severe acute respiratory syndrome (SARS) cases from 2020 to 2023 in Brazil, along medium and long term.
Retrospective cohort study using notification data of SARS classified as COVID-19 from the Brazilian National Information System, "Sistema de Vigilância Epidemiológica (SIVEP)," during the period 2020 to 2023. Data included demographics, comorbidities, vaccination status, number of COVID-19 vaccine doses, city of residence, and survival outcomes. Classic Cox, Cox mixed effects, and Cox fragility models were used to assess medium and long-term risks of dying post-COVID.
In the medium and long-term periods studied, 5,157 deaths were recorded out of 15,147 reported SARS/COVID-19 cases. Of these deaths, 91.5% ( = 4,720) occurred within the first year, while 8,5% (N = 437) after the first year. People without formal education, the older adult, had higher percentages of deaths in both periods. In the medium-term post-COVID period, the risk of death was reduced by 8% for those who had been vaccinated while in the long-term post-COVID period, the risk of death almost doubled for those who had been vaccinated. While in the medium term, there was a reduction in mortality risk for those who took two or three doses, in the long term the risk of death was greater for those who took one or two doses.
The protective effect of COVID-19 immunization was observed up to one year after the first symptoms. After one year, the effect was reversed, showing an increased risk of death for those vaccinated. These results highlight the need for further research to elucidate the factors that contribute to these findings.
文献中很少有关于巴西新冠疫情中长期后死亡情况的研究,尤其是那些出现严重临床疾病的患者。
本研究旨在调查2020年至2023年巴西严重急性呼吸综合征(SARS)病例新冠疫情中长期后死亡的相关因素。
采用回顾性队列研究,使用巴西国家信息系统“流行病学监测系统(SIVEP)”中2020年至2023年期间归类为新冠病毒病的SARS通报数据。数据包括人口统计学信息、合并症、疫苗接种状况、新冠疫苗接种剂量数、居住城市和生存结果。使用经典Cox模型、Cox混合效应模型和Cox脆弱性模型评估新冠疫情中长期后死亡风险。
在研究的中长期期间,15147例报告的SARS/新冠病毒病病例中有5157例死亡。在这些死亡病例中,91.5%(n = 4720)发生在第一年内,而8.5%(n = 437)发生在第一年后。未受过正规教育的老年人在两个时期的死亡百分比都较高。在新冠疫情中期,接种疫苗者的死亡风险降低了8%,而在新冠疫情长期,接种疫苗者的死亡风险几乎增加了一倍。虽然在中期,接种两剂或三剂疫苗者的死亡风险有所降低,但在长期,接种一剂或两剂疫苗者的死亡风险更高。
在出现首次症状后的一年内观察到新冠病毒免疫的保护作用。一年后,这种作用发生逆转,表明接种疫苗者的死亡风险增加。这些结果凸显了进一步研究以阐明促成这些发现的因素的必要性。